http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5856565-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21f23f0c43864bd4d632cd6023e4a66a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14 |
| filingDate | 1995-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e1944bb7a17334d4f0741a9255c33f |
| publicationDate | 1999-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5856565-A |
| titleOfInvention | Ng-monomethyl-l-argine hydrochloride derivatives and their use in the treatment of septic shock |
| abstract | A process for preparing crystalline N G -monomethyl-L-arginine hydrochloride is disclosed. The process comprises dissolving N G -monomethyl-L-arginine in hydrochloric acid and crystallising out N G -monomethyl-L-arginine hydrochloride. The crystallising step requires several months at low temperature. However, the process can be facilitated by seeding with crystals of N G -monomethyl-L-arginine hydrochloride. Alternatively, crystalline N G -monomethyl-L-arginine hydrochloride can be prepared by dissolving a salt of N G -monomethyl-L-arginine other than the hydrochloride salt with hydrochloric acid and removing the original salt forming ion by crystallising out the hydrochloride salt. |
| priorityDate | 1992-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.